Emerging Infectious Disease
MRIGlobal’s emerging infectious disease services span all stages of the diagnostic product development process, beginning with research and development through product clearance and launch.
Our infectious disease diagnostics R&D and IVD product development capabilities include, but are not limited to:
- Development of methods, platforms, and molecular and immunological assays
- Turnkey, outsourcing solutions for commercial and government clients
- Accelerated product development through analytical verification and clinical validation phases
Kyle Parker inspects a reagent cartridge prior to loading clinical samples for analysis with a point-of-care device.
MRIGlobal scientists conduct research and development with commercial companies to improve emerging infectious disease diagnostic technologies with the goal of advancing these technologies into verification and validation phases of clinical product development.